Pamorelin-LA 3.75mg Injection Vial

babies: pamorelin-la injection is unsafe in babies. lactating mothers: it is contraindicated.
studies have shown evidence of medicine in breast milk. it causes toxicity to the baby.
pregnancy: pamorelin-la injection is contraindicated in pregnancy. studies on pregnant women and animals have shown significant harmful effects on the developing baby.
driving: pamorelin-la injection may decrease alertness, affects vision, and may cause dizziness & sleep. do not drive if these symptoms occur.
alcohol: it is not known if it is safe to consume alcohol during pamorelin-la injections. talk to your doctor.
kidney: pamorelin-la injection should be used in caution with patients suffering from kidney disease. you may require dosage adjustment and regular monitoring of kidney function.
seek doctor’s advice before using this medication liver: pamorelin-la injection should be used in caution with patients suffering from liver disease. you may require dosage adjustment and regular monitoring of liver function.
seek a doctor’s advice before using this medication..

increased sweating back pain tingling or pricking sensation hot flashes erectile dysfunction.

sex hormones such as luteinizing hormone (lh) and follicle stimulating hormone (fsh) result in lowering steroidogenesis, which decreases testosterone levels in males and estrogen in females..

if you miss a dose, please consult your doctor..

• pamorelin-la injections are helpful in the treatment of advanced prostate cancer or local metastases • it is injected under the skin or into a muscle • do not take an injection yourself • do not drink alcohol and quit smoking • pamorelin-la can cause dizziness and blurred vision. don't drive or do anything that requires concentration • this medicine may be harmful to your developing baby, so use a non-hormonal method of contraception, such as a condom, to prevent pregnancy during treatment • do not go for long-term treatment.
it can increase the risk of bone loss and fractures • pamorelin-la will stop menstruation and may start 7-12 weeks after the last injection. if menstrual bleeding occurs even after administration of the injection, see your doctor • tell your doctor if you are pregnant or intend to be pregnant • do not use this injection for children less than 12 years of age • if any side effects persist, please consult your doctor • do not stop this injection or adding any other medications without consulting your doctor.

contraindicated: • pamorelin-la + bepridil: concomitant use may result in an increased risk of qt- interval prolongation • pamorelin-la + cisapride: concomitant use may result in an increased risk of qt- interval prolongation • pamorelin-la + dronedarone: concomitant use may result in an increased risk of qt- interval prolongation • pamorelin-la + pimozide: concomitant use may result in an increased risk of qt- interval prolongation major: • pamorelin-la + amisulpride: concomitant use may result in an increased risk of serious ventricular arrhythmias such as torsades de pointes. • pamorelin-la + chlorpromazine: concomitant use may result in an increased risk of qt-interval prolongation.